Matthew T David - Net Worth and Insider Trading
Matthew T David Net Worth
The estimated net worth of Matthew T David is at least $25,862 dollars as of 2024-12-28. Matthew T David is the Interim CEO and CFO of Cormedix Inc and owns about 3,150 shares of Cormedix Inc (CRMD) stock worth over $25,862. Details can be seen in Matthew T David's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Matthew T David has not made any transactions after 2021-12-06 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Matthew T David
Matthew T David Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Matthew T David owns 1 companies in total, including Cormedix Inc (CRMD) .
Click here to see the complete history of Matthew T David’s form 4 insider trades.
Insider Ownership Summary of Matthew T David
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| CRMD | Cormedix Inc | 2021-12-06 | EVP & Chief Financial Officer |
Matthew T David Latest Holdings Summary
Matthew T David currently owns a total of 1 stock. Matthew T David owns 3,150 shares of Cormedix Inc (CRMD) as of December 6, 2021, with a value of $25,862.
Latest Holdings of Matthew T David
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| CRMD | Cormedix Inc | 2021-12-06 | 3,150 | 8.21 | 25,862 |
Holding Weightings of Matthew T David
Matthew T David Form 4 Trading Tracker
According to the SEC Form 4 filings, Matthew T David has made a total of 4 transactions in Cormedix Inc (CRMD) over the past 5 years, including 4 buys and 0 sells. The most-recent trade in Cormedix Inc is the acquisition of 1,000 shares on December 6, 2021, which cost Matthew T David around $4,500.
Insider Trading History of Matthew T David
- 1
Matthew T David Trading Performance
GuruFocus tracks the stock performance after each of Matthew T David's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Matthew T David is 21.19%. GuruFocus also compares Matthew T David's trading performance to market benchmark return within the same time period. The performance of stocks bought by Matthew T David within 3 months outperforms 3 times out of 4 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Matthew T David's insider trading performs compared to the benchmark.
Performance of Matthew T David
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 11.13 | | | | | |
| Relative Return to S&P 500(%) | 11.13 | | | | | |
Matthew T David Ownership Network
Matthew T David Owned Company Details
What does Cormedix Inc do?
Who are the key executives at Cormedix Inc?
Matthew T David is the EVP & Chief Financial Officer of Cormedix Inc. Other key executives at Cormedix Inc include EVP & Head of Clinical Ops. Elizabeth Masson , Chief Commercial Officer Erin Mistry , and director & Chief Executive Officer Joseph Todisco .
Cormedix Inc (CRMD) Insider Trades Summary
Over the past 18 months, Matthew T David made no insider transaction in Cormedix Inc (CRMD). Other recent insider transactions involving Cormedix Inc (CRMD) include a net purchase of 23,561 shares made by Joseph Todisco , a net purchase of 2,500 shares made by Erin Mistry , and a net sale of 140,027 shares made by Elizabeth Masson .
In summary, during the past 3 months, insiders sold 140,027 shares of Cormedix Inc (CRMD) in total and bought 1,500 shares, with a net sale of 138,527 shares. During the past 18 months, 140,027 shares of Cormedix Inc (CRMD) were sold and 32,061 shares were bought by its insiders, resulting in a net sale of 107,966 shares.
Cormedix Inc (CRMD)'s detailed insider trading history can be found in Insider Trading Tracker table.
Cormedix Inc Insider Transactions
Matthew T David Mailing Address
Above is the net worth, insider trading, and ownership report for Matthew T David. You might contact Matthew T David via mailing address: 300 Connell Drive, Suite 4200, Berkeley Heights Nj 07922.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
